CD274 Rabbit Polyclonal Antibody

CD274 Rabbit Polyclonal Antibody

To Order Contact Us Below:

    CD274 Polyclonal Antibody
    ES8791-100ul 100ul
    EUR 334.8
    Description: A Rabbit Polyclonal antibody against CD274 from Human. This antibody is tested and validated for IHC, WB, ELISA

    CD274 Polyclonal Antibody
    ES8791-50ul 50ul
    EUR 248.4
    Description: A Rabbit Polyclonal antibody against CD274 from Human. This antibody is tested and validated for IHC, WB, ELISA

    CD274 Antibody
    1-CSB-PA004911GA01HU
    • EUR 716.40
    • EUR 399.60
    • 150ul
    • 50ul
    Description: A polyclonal antibody against CD274. Recognizes CD274 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC

    CD274 Antibody
    DF6526 200ul
    EUR 420

    CD274 Antibody
    1-CSB-PA878942ESR1HU
    • EUR 266.40
    • EUR 402.00
    • 100ul
    • 50ul
    Description: A polyclonal antibody against CD274. Recognizes CD274 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC; Recommended dilution: IHC:1:20-1:200

    CD274 Antibody
    32363-100ul 100ul
    EUR 302.4

    CD274 Antibody
    43858-100ul 100ul
    EUR 302.4

    CD274 antibody
    70R-16265 50 ul
    EUR 522
    Description: Rabbit polyclonal CD274 antibody

    CD274 Antibody
    ABD6526 100 ug
    EUR 525.6

    Polyclonal CD274 Antibody (C-term)
    APR03998G 0.1ml
    EUR 580.8
    Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human CD274 (C-term). This antibody is tested and proven to work in the following applications:

    CD274
    274A-100T 100 test
    EUR 490.56

    CD274
    274B-01MG 0,1 test
    EUR 396.96

    CD274
    274CFB-100T 100 test
    EUR 546.72

    CD274
    274F-100T 100 test
    EUR 434.4

    CD274
    274PE-100T 100 test
    EUR 528

    CD274
    274PU-01MG 0,1 test
    EUR 303.36

    CD274
    PR27312 2 ug
    EUR 229.2

    Anti-PD-L1 (CD274) Rabbit Monoclonal Antibody
    M00109 100ug/vial
    EUR 476.4
    Description: Rabbit Monoclonal PD-L1 (CD274) Antibody. Validated in IHC-P, WB and tested in Human, Mouse, Rat.

    Polyclonal CD274 Antibody - C-terminal region
    APR01550G 0.05mg
    EUR 633.6
    Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human CD274 - C-terminal region. This antibody is tested and proven to work in the following applications:

    CD274(PD1L1) Antibody
    48238-100ul 100ul
    EUR 399.6

    CD274(PD1L1) Antibody
    48238-50ul 50ul
    EUR 286.8

    CD274 Antibody (FITC)
    abx140489-100tests 100 tests
    EUR 510

    Anti-CD274 antibody
    STJ113753 100 µl
    EUR 332.4
    Description: This gene encodes an immune inhibitory receptor ligand that is expressed by hematopoietic and non-hematopoietic cells, such as T cells and B cells and various types of tumor cells. The encoded protein is a type I transmembrane protein that has immunoglobulin V-like and C-like domains. Interaction of this ligand with its receptor inhibits T-cell activation and cytokine production. During infection or inflammation of normal tissue, this interaction is important for preventing autoimmunity by maintaining homeostasis of the immune response. In tumor microenvironments, this interaction provides an immune escape for tumor cells through cytotoxic T-cell inactivation. Expression of this gene in tumor cells is considered to be prognostic in many types of human malignancies, including colon cancer and renal cell carcinoma. Alternative splicing results in multiple transcript variants.

    Anti-CD274 antibody
    STJ160016 1 mL C
    EUR 652.8
    Description: Programmed Death-Ligand 1 (PD-L1), also known as CD274 or B7 Homolog 1 (B7-H1), is a transmembrane protein involved in suppressing the immune system and rendering tumor cells resistant to CD8+ T cell-mediated lysis through binding of the Programmed Death-1 (PD-1) receptor. Overexpression of PD-L1 may allow cancer cells to evade the actions of the host immune system. In renal cell carcinoma, upregulation of PD-L1 has been linked to increased tumor aggressiveness and risk of death, and, in ovarian cancer, higher expression of this protein has lead to significantly poorer prognosis. PD-L1 has also been linked to systemic lupus erythematosus and cutaneous melanoma. When considered in adjunct with CD8+ tumor-infiltrating lymphocyte density, expression levels of PD-L1 may be a useful predictor of multiple cancer types, including stage III non-small cell lung cancer, hormone receptor negative breast cancer, and sentinel lymph node melanoma.

    Anti-CD274 Antibody
    STJ502399 100 µg
    EUR 571.2

    Anti-CD274 antibody
    STJ22985 100 µl
    EUR 332.4
    Description: This gene encodes an immune inhibitory receptor ligand that is expressed by hematopoietic and non-hematopoietic cells, such as T cells and B cells and various types of tumor cells. The encoded protein is a type I transmembrane protein that has immunoglobulin V-like and C-like domains. Interaction of this ligand with its receptor inhibits T-cell activation and cytokine production. During infection or inflammation of normal tissue, this interaction is important for preventing autoimmunity by maintaining homeostasis of the immune response. In tumor microenvironments, this interaction provides an immune escape for tumor cells through cytotoxic T-cell inactivation. Expression of this gene in tumor cells is considered to be prognostic in many types of human malignancies, including colon cancer and renal cell carcinoma. Alternative splicing results in multiple transcript variants.

    Anti-CD274 antibody
    STJ98996 200 µl
    EUR 236.4
    Description: Rabbit polyclonal to CD274.

    Rabbit Anti-CD274 monoclonal antibody, clone KK19-06
    CAB-722RH 100 ul
    EUR 932.4

    anti-CD274
    YF-PA26076 50 ul
    EUR 400.8
    Description: Mouse polyclonal to CD274

    Polyclonal Goat Anti-CD274 / PD-L1 Antibody
    APG00067G 0.1mg
    EUR 580.8
    Description: A polyclonal antibody raised in Goat that recognizes and binds to Human Goat Anti-CD274 / PD-L1 . This antibody is tested and proven to work in the following applications:

    Polyclonal B7-H1 / PD-L1 / CD274 Antibody
    APR03374G 0.05ml
    EUR 580.8
    Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human B7-H1 / PD-L1 / CD274 . This antibody is tested and proven to work in the following applications:

    CD274(PD1L1) Conjugated Antibody
    C48238 100ul
    EUR 476.4

    Anti-CD274 Antibody (Biotin)
    STJ502400 100 µg
    EUR 703.2

    Anti-CD274 Antibody (FITC)
    STJ502401 100 µg
    EUR 703.2

    Anti-PD-L1 (CD274) (B7-H1), Rabbit Monoclonal Antibody
    A1824-50 each Ask for price

    Goat Anti Human Cd274 (C-Terminal) Polyclonal Antibody
    CPBT-65080GH 0.1 mg
    EUR 1008

    CD274 cloning plasmid
    CSB-CL878942HU-10ug 10ug
    EUR 279.6
    Description: A cloning plasmid for the CD274 gene.

    CD274 Blocking Peptide
    DF6526-BP 1mg
    EUR 234

    PD-L1, CD274
    E6TA00108 0.1mg
    EUR 411.6

    pDONR223-CD274 Plasmid
    PVTB00385 2 ug
    EUR 427.2

    pCR4-TOPO-CD274
    PVT14234 2 ug
    EUR 594

    pGEX-4T-CD274
    PVT14476 2 ug
    EUR 843.6

    CD274, mouse recombinant
    7311-100 each
    EUR 444

    PD-L1 (CD274)
    100443-1 100 µg
    EUR 320
    Description: Human secreted Programmed Cell Death 1 Ligand 1 (PD-L1) protein, also known as CD274, PDCD1L1, and B7 homolog 1 (B7-H1), GenBank Accession No. NM_014143, a.a. 19-239, expressed in an E. coli expression system. MW = 25 kDa.

    PD-L1 (CD274)
    100443-2 1 mg
    EUR 2720
    Description: Human secreted Programmed Cell Death 1 Ligand 1 (PD-L1) protein, also known as CD274, PDCD1L1, and B7 homolog 1 (B7-H1), GenBank Accession No. NM_014143, a.a. 19-239, expressed in an E. coli expression system. MW = 25 kDa.

    anti- PD-L1/CD274 antibody
    FNab06280 100µg
    EUR 606.3
    Description: Antibody raised against PD-L1/CD274

    anti- PD-L1/CD274 antibody
    FNab06281 100µg
    EUR 658.5
    Description: Antibody raised against PD-L1/CD274

    Anti-PD-L1/CD274 Antibody
    PA1851 100ug/vial
    EUR 352.8

    Anti-PD-L1/CD274 antibody
    PAab06280 100 ug
    EUR 426

    Anti-PD-L1/CD274 Antibody
    PB9154 100ug/vial
    EUR 352.8

    Anti-PD-L1/CD274 Antibody
    PB9994 100ug/vial
    EUR 352.8

    Anti-CD274 / PD-L1 antibody
    STJ70646 100 µg
    EUR 430.8

    Anti-PD-L1 (CD274) (B7-H1) Rabbit Monoclonal Antibody, Clone#RM320
    M00109-1 100uL
    EUR 512.4
    Description: Anti-PD-L1 (CD274) (B7-H1) Rabbit Monoclonal Antibody, Clone#RM320 tested in WB, IHC, reactive to Human

    Mouse Anti Human Cd274 Monoclonal Antibody
    CABT-47434MH 0.2 mg
    EUR 920.4

    Anti-CD274 / PD-L1, Biotinylated antibody
    STJ73200 100 µg
    EUR 430.8

    PD-L1 Antibody / B7-H1 / CD274
    F55054-0.1ML 0.1ml
    EUR 399

    PD-L1 Antibody / B7-H1 / CD274
    R32479 100 ug
    EUR 419

    PD-L1 Antibody / B7-H1 / CD274
    R32579 100 ug
    EUR 419

    PD-L1 Antibody / B7-H1 / CD274
    V7822-100UG 100 ug
    EUR 499
    Description: PD-L1 is a checkpoint regulator in immune cells, it is expressed on immune or non-hematopoietic cells. Expression of the protein is seen during pregnancy where it has a role in suppressing the immune system. PD-L1 induces an inhibitory signal in activated T-cells and promotes T-cell apoptosis. It is overexpressed in a number of different cancers where it is believed to play a significant role in the cancer s ability to evade the immune system.

    PD-L1 Antibody / B7-H1 / CD274
    V7822-20UG 20 ug
    EUR 219
    Description: PD-L1 is a checkpoint regulator in immune cells, it is expressed on immune or non-hematopoietic cells. Expression of the protein is seen during pregnancy where it has a role in suppressing the immune system. PD-L1 induces an inhibitory signal in activated T-cells and promotes T-cell apoptosis. It is overexpressed in a number of different cancers where it is believed to play a significant role in the cancer s ability to evade the immune system.

    PD-L1 Antibody / B7-H1 / CD274
    V7822SAF-100UG 100 ug
    EUR 499
    Description: PD-L1 is a checkpoint regulator in immune cells, it is expressed on immune or non-hematopoietic cells. Expression of the protein is seen during pregnancy where it has a role in suppressing the immune system. PD-L1 induces an inhibitory signal in activated T-cells and promotes T-cell apoptosis. It is overexpressed in a number of different cancers where it is believed to play a significant role in the cancer s ability to evade the immune system.

    PD-L1 Antibody / B7-H1 / CD274
    V7823-100UG 100 ug
    EUR 499
    Description: PD-L1 is a checkpoint regulator in immune cells, it is expressed on immune or non-hematopoietic cells. Expression of the protein is seen during pregnancy where it has a role in suppressing the immune system. PD-L1 induces an inhibitory signal in activated T-cells and promotes T-cell apoptosis. It is overexpressed in a number of different cancers where it is believed to play a significant role in the cancer s ability to evade the immune system.

    PD-L1 Antibody / B7-H1 / CD274
    V7823-20UG 20 ug
    EUR 219
    Description: PD-L1 is a checkpoint regulator in immune cells, it is expressed on immune or non-hematopoietic cells. Expression of the protein is seen during pregnancy where it has a role in suppressing the immune system. PD-L1 induces an inhibitory signal in activated T-cells and promotes T-cell apoptosis. It is overexpressed in a number of different cancers where it is believed to play a significant role in the cancer s ability to evade the immune system.

    PD-L1 Antibody / B7-H1 / CD274
    V7823SAF-100UG 100 ug
    EUR 499
    Description: PD-L1 is a checkpoint regulator in immune cells, it is expressed on immune or non-hematopoietic cells. Expression of the protein is seen during pregnancy where it has a role in suppressing the immune system. PD-L1 induces an inhibitory signal in activated T-cells and promotes T-cell apoptosis. It is overexpressed in a number of different cancers where it is believed to play a significant role in the cancer s ability to evade the immune system.

    PD-L1 Antibody / B7-H1 / CD274
    V7974-100UG 100 ug
    EUR 499
    Description: PD-L1 is a checkpoint regulator in immune cells, it is expressed on immune or non-hematopoietic cells. Expression of the protein is seen during pregnancy where it has a role in suppressing the immune system. PD-L1 induces an inhibitory signal in activated T-cells and promotes T-cell apoptosis. It is overexpressed in a number of different cancers where it is believed to play a significant role in the cancer s ability to evade the immune system.

    PD-L1 Antibody / B7-H1 / CD274
    V7974-20UG 20 ug
    EUR 219
    Description: PD-L1 is a checkpoint regulator in immune cells, it is expressed on immune or non-hematopoietic cells. Expression of the protein is seen during pregnancy where it has a role in suppressing the immune system. PD-L1 induces an inhibitory signal in activated T-cells and promotes T-cell apoptosis. It is overexpressed in a number of different cancers where it is believed to play a significant role in the cancer s ability to evade the immune system.

    PD-L1 Antibody / B7-H1 / CD274
    V7974SAF-100UG 100 ug
    EUR 499
    Description: PD-L1 is a checkpoint regulator in immune cells, it is expressed on immune or non-hematopoietic cells. Expression of the protein is seen during pregnancy where it has a role in suppressing the immune system. PD-L1 induces an inhibitory signal in activated T-cells and promotes T-cell apoptosis. It is overexpressed in a number of different cancers where it is believed to play a significant role in the cancer s ability to evade the immune system.

    PD-L1 Antibody / B7-H1 / CD274
    V7988-100UG 100 ug
    EUR 499
    Description: Engagement of CD28 by B7-1 (CD80) or B7-2 (CD86) in the presence of antigen promotes T-cell proliferation, cytokine production, differentiation of effector T-cells and the induction of BCLX, a promoter of T-cell survival. Engagement of CTLA4 by B7-1 or B7-2, on the other hand, may inhibit proliferation and interleukin-2 (IL-2) production. PD-L1 is 290-amino acid type I transmembrane protein, which is 20% and 15% identical to B7-1 and B7-2, respectively, has immunoglobulin V-like and C-like domains and a 30-amino acid cytoplasmic tail. PD-L1 does not bind CD28, cytotoxic T-lymphocyte A4 or ICOS (inducible co-stimulator). IL-2, although produced in small amounts, is required for the effect of PD-L1 co-stimulation. PD-L2 protein contains a signal sequence, IgV- and IgC-like domains, a transmembrane region and a cytoplasmic region. The constitutive expression of PD-L1 and PD-L2 on parenchymal cells of heart, lung and kidney suggests that the PD-1-PD-L system could provide unique negative signaling to help prevent autoimmune diseases.

    PD-L1 Antibody / B7-H1 / CD274
    V7988-20UG 20 ug
    EUR 219
    Description: Engagement of CD28 by B7-1 (CD80) or B7-2 (CD86) in the presence of antigen promotes T-cell proliferation, cytokine production, differentiation of effector T-cells and the induction of BCLX, a promoter of T-cell survival. Engagement of CTLA4 by B7-1 or B7-2, on the other hand, may inhibit proliferation and interleukin-2 (IL-2) production. PD-L1 is 290-amino acid type I transmembrane protein, which is 20% and 15% identical to B7-1 and B7-2, respectively, has immunoglobulin V-like and C-like domains and a 30-amino acid cytoplasmic tail. PD-L1 does not bind CD28, cytotoxic T-lymphocyte A4 or ICOS (inducible co-stimulator). IL-2, although produced in small amounts, is required for the effect of PD-L1 co-stimulation. PD-L2 protein contains a signal sequence, IgV- and IgC-like domains, a transmembrane region and a cytoplasmic region. The constitutive expression of PD-L1 and PD-L2 on parenchymal cells of heart, lung and kidney suggests that the PD-1-PD-L system could provide unique negative signaling to help prevent autoimmune diseases.

    PD-L1 Antibody / B7-H1 / CD274
    V7988SAF-100UG 100 ug
    EUR 499
    Description: Engagement of CD28 by B7-1 (CD80) or B7-2 (CD86) in the presence of antigen promotes T-cell proliferation, cytokine production, differentiation of effector T-cells and the induction of BCLX, a promoter of T-cell survival. Engagement of CTLA4 by B7-1 or B7-2, on the other hand, may inhibit proliferation and interleukin-2 (IL-2) production. PD-L1 is 290-amino acid type I transmembrane protein, which is 20% and 15% identical to B7-1 and B7-2, respectively, has immunoglobulin V-like and C-like domains and a 30-amino acid cytoplasmic tail. PD-L1 does not bind CD28, cytotoxic T-lymphocyte A4 or ICOS (inducible co-stimulator). IL-2, although produced in small amounts, is required for the effect of PD-L1 co-stimulation. PD-L2 protein contains a signal sequence, IgV- and IgC-like domains, a transmembrane region and a cytoplasmic region. The constitutive expression of PD-L1 and PD-L2 on parenchymal cells of heart, lung and kidney suggests that the PD-1-PD-L system could provide unique negative signaling to help prevent autoimmune diseases.

    PD-L1 Antibody / B7-H1 / CD274
    V8009-100UG 100 ug
    EUR 499
    Description: PD-L1 is a checkpoint regulator in immune cells, it is expressed on immune or non-hematopoietic cells. Expression of the protein is seen during pregnancy where it has a role in suppressing the immune system. PD-L1 induces an inhibitory signal in activated T-cells and promotes T-cell apoptosis. It is overexpressed in a number of different cancers where it is believed to play a significant role in the cancer s ability to evade the immune system.

    PD-L1 Antibody / B7-H1 / CD274
    V8009-20UG 20 ug
    EUR 219
    Description: PD-L1 is a checkpoint regulator in immune cells, it is expressed on immune or non-hematopoietic cells. Expression of the protein is seen during pregnancy where it has a role in suppressing the immune system. PD-L1 induces an inhibitory signal in activated T-cells and promotes T-cell apoptosis. It is overexpressed in a number of different cancers where it is believed to play a significant role in the cancer s ability to evade the immune system.

    PD-L1 Antibody / B7-H1 / CD274
    V8009SAF-100UG 100 ug
    EUR 499
    Description: PD-L1 is a checkpoint regulator in immune cells, it is expressed on immune or non-hematopoietic cells. Expression of the protein is seen during pregnancy where it has a role in suppressing the immune system. PD-L1 induces an inhibitory signal in activated T-cells and promotes T-cell apoptosis. It is overexpressed in a number of different cancers where it is believed to play a significant role in the cancer s ability to evade the immune system.

    PD-L1 Antibody / B7-H1 / CD274
    V8067-100UG 100 ug
    EUR 499
    Description: PD-L1 is a checkpoint regulator in immune cells, it is expressed on immune or non-hematopoietic cells. Expression of the protein is seen during pregnancy where it has a role in suppressing the immune system. PD-L1 induces an inhibitory signal in activated T-cells and promotes T-cell apoptosis. It is overexpressed in a number of different cancers where it is believed to play a significant role in the cancer’s ability to evade the immune system.

    PD-L1 Antibody / B7-H1 / CD274
    V8067-20UG 20 ug
    EUR 219
    Description: PD-L1 is a checkpoint regulator in immune cells, it is expressed on immune or non-hematopoietic cells. Expression of the protein is seen during pregnancy where it has a role in suppressing the immune system. PD-L1 induces an inhibitory signal in activated T-cells and promotes T-cell apoptosis. It is overexpressed in a number of different cancers where it is believed to play a significant role in the cancer’s ability to evade the immune system.

    PD-L1 Antibody / B7-H1 / CD274
    V8067SAF-100UG 100 ug
    EUR 499
    Description: PD-L1 is a checkpoint regulator in immune cells, it is expressed on immune or non-hematopoietic cells. Expression of the protein is seen during pregnancy where it has a role in suppressing the immune system. PD-L1 induces an inhibitory signal in activated T-cells and promotes T-cell apoptosis. It is overexpressed in a number of different cancers where it is believed to play a significant role in the cancer’s ability to evade the immune system.

    PD-L1 Antibody / B7-H1 / CD274
    V3955-100UG 100 ug
    EUR 499
    Description: Engagement of CD28 by B7-1 (CD80) or B7-2 (CD86) in the presence of antigen promotes T-cell proliferation, cytokine production, differentiation of effector T-cells and the induction of BCLX, a promoter of T-cell survival. recruitment of CTLA4 by B7-1 or B7-2, on the other hand, may inhibit proliferation and interleukin-2 (IL-2) production. PD-L1 is 290-amino acid type I transmembrane protein, which is 20% and 15% identical to B7-1 and B7-2, respectively, has immunoglobulin V-like and C-like domains and a 30-amino acid cytoplasmic tail. PD-L1 does not bind CD28, cytotoxic T-lymphocyte A4 or ICOS (inducible co-stimulator). IL-2, although produced in small amounts, is required for the effect of PD-L1 co-stimulation. PD-L2 protein contains a signal sequence, IgV- and IgC-like domains, a transmembrane region and a cytoplasmic region. Constitutive expression of PD-L1 and PD-L2 on parenchymal cells of heart, lung and kidney suggests that the PD-1-PD-L system could provide unique negative signaling to help prevent autoimmune diseases.

    PD-L1 Antibody / B7-H1 / CD274
    V3955-20UG 20 ug
    EUR 219
    Description: Engagement of CD28 by B7-1 (CD80) or B7-2 (CD86) in the presence of antigen promotes T-cell proliferation, cytokine production, differentiation of effector T-cells and the induction of BCLX, a promoter of T-cell survival. recruitment of CTLA4 by B7-1 or B7-2, on the other hand, may inhibit proliferation and interleukin-2 (IL-2) production. PD-L1 is 290-amino acid type I transmembrane protein, which is 20% and 15% identical to B7-1 and B7-2, respectively, has immunoglobulin V-like and C-like domains and a 30-amino acid cytoplasmic tail. PD-L1 does not bind CD28, cytotoxic T-lymphocyte A4 or ICOS (inducible co-stimulator). IL-2, although produced in small amounts, is required for the effect of PD-L1 co-stimulation. PD-L2 protein contains a signal sequence, IgV- and IgC-like domains, a transmembrane region and a cytoplasmic region. Constitutive expression of PD-L1 and PD-L2 on parenchymal cells of heart, lung and kidney suggests that the PD-1-PD-L system could provide unique negative signaling to help prevent autoimmune diseases.

    PD-L1 Antibody / B7-H1 / CD274
    V3955BTN 500 ul
    EUR 499
    Description: PD-L1 is a checkpoint regulator in immune cells, it is expressed on immune or non-hematopoietic cells. Expression of the protein is seen during pregnancy where it has a role in suppressing the immune system. PD-L1 induces an inhibitory signal in activated T-cells and promotes T-cell apoptosis. It is overexpressed in a number of different cancers where it is believed to play a significant role in the cancer s ability to evade the immune system.

    PD-L1 Antibody / B7-H1 / CD274
    V3955PE-100T 100 Tests
    EUR 499
    Description: PD-L1 is a checkpoint regulator in immune cells, it is expressed on immune or non-hematopoietic cells. Expression of the protein is seen during pregnancy where it has a role in suppressing the immune system. PD-L1 induces an inhibitory signal in activated T-cells and promotes T-cell apoptosis. It is overexpressed in a number of different cancers where it is believed to play a significant role in the cancer s ability to evade the immune system.

    PD-L1 Antibody / B7-H1 / CD274
    V3955SAF-100UG 100 ug
    EUR 499
    Description: Engagement of CD28 by B7-1 (CD80) or B7-2 (CD86) in the presence of antigen promotes T-cell proliferation, cytokine production, differentiation of effector T-cells and the induction of BCLX, a promoter of T-cell survival. recruitment of CTLA4 by B7-1 or B7-2, on the other hand, may inhibit proliferation and interleukin-2 (IL-2) production. PD-L1 is 290-amino acid type I transmembrane protein, which is 20% and 15% identical to B7-1 and B7-2, respectively, has immunoglobulin V-like and C-like domains and a 30-amino acid cytoplasmic tail. PD-L1 does not bind CD28, cytotoxic T-lymphocyte A4 or ICOS (inducible co-stimulator). IL-2, although produced in small amounts, is required for the effect of PD-L1 co-stimulation. PD-L2 protein contains a signal sequence, IgV- and IgC-like domains, a transmembrane region and a cytoplasmic region. Constitutive expression of PD-L1 and PD-L2 on parenchymal cells of heart, lung and kidney suggests that the PD-1-PD-L system could provide unique negative signaling to help prevent autoimmune diseases.

    PD-L1 Antibody / B7-H1 / CD274
    V8598-100UG 100 ug
    EUR 499
    Description: PD-L1 is a checkpoint regulator in immune cells, it is expressed on immune or non-hematopoietic cells. Expression of the protein is seen during pregnancy where it has a role in suppressing the immune system. PD-L1 induces an inhibitory signal in activated T-cells and promotes T-cell apoptosis. It is overexpressed in a number of different cancers where it is believed to play a significant role in the cancer s ability to evade the immune system.

    PD-L1 Antibody / B7-H1 / CD274
    V8598-20UG 20 ug
    EUR 219
    Description: PD-L1 is a checkpoint regulator in immune cells, it is expressed on immune or non-hematopoietic cells. Expression of the protein is seen during pregnancy where it has a role in suppressing the immune system. PD-L1 induces an inhibitory signal in activated T-cells and promotes T-cell apoptosis. It is overexpressed in a number of different cancers where it is believed to play a significant role in the cancer s ability to evade the immune system.

    PD-L1 Antibody / B7-H1 / CD274
    V8598SAF-100UG 100 ug
    EUR 499
    Description: PD-L1 is a checkpoint regulator in immune cells, it is expressed on immune or non-hematopoietic cells. Expression of the protein is seen during pregnancy where it has a role in suppressing the immune system. PD-L1 induces an inhibitory signal in activated T-cells and promotes T-cell apoptosis. It is overexpressed in a number of different cancers where it is believed to play a significant role in the cancer s ability to evade the immune system.

    PD-L1 Antibody / B7-H1 / CD274
    V8640-100UG 100 ug
    EUR 499
    Description: PD-L1 is a checkpoint regulator in immune cells, it is expressed on immune or non-hematopoietic cells. Expression of the protein is seen during pregnancy where it has a role in suppressing the immune system. PD-L1 induces an inhibitory signal in activated T-cells and promotes T-cell apoptosis. It is overexpressed in a number of different cancers where it is believed to play a significant role in the cancer s ability to evade the immune system.

    PD-L1 Antibody / B7-H1 / CD274
    V8640-20UG 20 ug
    EUR 219
    Description: PD-L1 is a checkpoint regulator in immune cells, it is expressed on immune or non-hematopoietic cells. Expression of the protein is seen during pregnancy where it has a role in suppressing the immune system. PD-L1 induces an inhibitory signal in activated T-cells and promotes T-cell apoptosis. It is overexpressed in a number of different cancers where it is believed to play a significant role in the cancer s ability to evade the immune system.

    PD-L1 Antibody / B7-H1 / CD274
    V8640SAF-100UG 100 ug
    EUR 499
    Description: PD-L1 is a checkpoint regulator in immune cells, it is expressed on immune or non-hematopoietic cells. Expression of the protein is seen during pregnancy where it has a role in suppressing the immune system. PD-L1 induces an inhibitory signal in activated T-cells and promotes T-cell apoptosis. It is overexpressed in a number of different cancers where it is believed to play a significant role in the cancer s ability to evade the immune system.

    PD-L1 Antibody / B7-H1 / CD274
    V8641-100UG 100 ug
    EUR 499
    Description: PD-L1 is a checkpoint regulator in immune cells, it is expressed on immune or non-hematopoietic cells. Expression of the protein is seen during pregnancy where it has a role in suppressing the immune system. PD-L1 induces an inhibitory signal in activated T-cells and promotes T-cell apoptosis. It is overexpressed in a number of different cancers where it is believed to play a significant role in the cancers ability to evade the immune system.

    PD-L1 Antibody / B7-H1 / CD274
    V8641-20UG 20 ug
    EUR 219
    Description: PD-L1 is a checkpoint regulator in immune cells, it is expressed on immune or non-hematopoietic cells. Expression of the protein is seen during pregnancy where it has a role in suppressing the immune system. PD-L1 induces an inhibitory signal in activated T-cells and promotes T-cell apoptosis. It is overexpressed in a number of different cancers where it is believed to play a significant role in the cancers ability to evade the immune system.

    PD-L1 Antibody / B7-H1 / CD274
    V8641SAF-100UG 100 ug
    EUR 499
    Description: PD-L1 is a checkpoint regulator in immune cells, it is expressed on immune or non-hematopoietic cells. Expression of the protein is seen during pregnancy where it has a role in suppressing the immune system. PD-L1 induces an inhibitory signal in activated T-cells and promotes T-cell apoptosis. It is overexpressed in a number of different cancers where it is believed to play a significant role in the cancers ability to evade the immune system.

    PD-L1 Antibody / B7-H1 / CD274
    V9155-100UG 100ug
    EUR 499
    Description: PD-L1 is a checkpoint regulator in immune cells, it is expressed on immune or non-hematopoietic cells.

    PD-L1 Antibody / B7-H1 / CD274
    V9155-20UG 20ug
    EUR 219
    Description: PD-L1 is a checkpoint regulator in immune cells, it is expressed on immune or non-hematopoietic cells.

    PD-L1 Antibody / B7-H1 / CD274
    V9155SAF-100UG 100ug
    EUR 499
    Description: PD-L1 is a checkpoint regulator in immune cells, it is expressed on immune or non-hematopoietic cells.

    Anti-PD-L1 (CD274) Neutralizing Antibody
    71213 100 µg
    EUR 505
    Description: Neutralizing recombinant chimeric murine/human monoclonal antibody recognizing the extracellular domain of PD-L1 and blocking the binding of PD-L1 to PD-1. This antibody has been shown to cross-react with mouse PD-L1. No other species have been tested.

    Human CD274 shRNA Plasmid
    20-abx959214
    • EUR 961.20
    • EUR 1345.20
    • 150 µg
    • 300 µg

    Mouse CD274 shRNA Plasmid
    20-abx975220
    • EUR 961.20
    • EUR 1345.20
    • 150 µg
    • 300 µg

    PD-L1 (CD274) siRNA
    20-abx910978
    • EUR 661.20
    • EUR 878.40
    • 15 nmol
    • 30 nmol

    PD-L1 (CD274) siRNA
    20-abx910979
    • EUR 661.20
    • EUR 878.40
    • 15 nmol
    • 30 nmol

    Anti-Hu CD274 PE
    1P-177-T025 25 tests
    EUR 168

    Anti-Hu CD274 PE
    1P-177-T100 100 tests
    EUR 288

    Anti-Hu CD274 APC
    1A-177-T100 100 tests
    EUR 288

    Anti-Hu CD274 FITC
    1F-177-T100 100 tests
    EUR 244.8

    Anti-Hu CD274 Purified
    11-177-C025 0.025 mg
    EUR 118.8

    Anti-Hu CD274 Purified
    11-177-C100 0.1 mg
    EUR 189.6

    CD274 protein (His tag)
    80R-2283 20 ug
    EUR 386.4
    Description: Purified recombinant Human CD274 Protein (His tag)

    CD274 protein (His tag)
    80R-2388 100 ug
    EUR 386.4
    Description: Purified recombinant Mouse CD274 protein (His tag)

    CD274 Mouse Recombinant Protein
    PROTQ9EP73 Regular: 20ug
    EUR 380.4
    Description: CD274 Mouse Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 246 amino acids (19-239 a.a) and having a molecular mass of 27.6kDa (Molecular size on SDS-PAGE will appear higher).;CD274 is fused to a 25 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.

    CD274 Human Recombinant Protein
    PROTQ9NZQ7 Regular: 10ug
    EUR 380.4
    Description: CD274 Human Recombinant produced in E. coli is a single polypeptide chain containing 245 amino acids (19-238) and having a molecular mass of 27.9kDa (Molecular weight on SDS-PAGE will appear higher).;CD274 is fused to a 25 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.

    pECMV-3-FLAG-CD274
    PVT14249 2 ug
    EUR 718.8

    pGEX-4T-CD274-m
    PVT14414 2 ug
    EUR 718.8

    pECMV-CD274-m-FLAG
    PVT14419 2 ug
    EUR 594

    CD274 Recombinant Protein (Human)
    RP037906 100 ug Ask for price

    CD274 Recombinant Protein (Mouse)
    RP122489 100 ug Ask for price

    CD274 Recombinant Protein (Rat)
    RP193907 100 ug Ask for price

    Mouse Anti Human Cd274 Monoclonal Antibody,FITC
    CABT-47432MH 0.1 mg
    EUR 795.6

    Rat Anti Mouse Cd274 Monoclonal Antibody,FITC
    CABT-47438RM 0.1 mg
    EUR 546

    Anti-PD-L1/B7-H1/CD274 Antibody
    A00109 100ug/vial
    EUR 352.8

    Anti-Hu CD274 Alexa Fluor700
    A7-177-T100 100 tests
    EUR 322.8

    CD274 ELISA Kit (Human) (OKBB00999)
    OKBB00999 96 Wells
    EUR 606
    Description: Description of target: Programmed death-ligand 1 (PD-L1), also known as cluster of differentiation 274 (CD274) or B7 homolog 1 (B7-H1), is a protein that in humans is encoded by the CD274 gene. PD-L1 is a 40kDa type 1 transmembrane protein that has been speculated to play a major role in suppressing the immune system during particular events such as pregnancy, tissue allografts, autoimmune disease and other disease states such as hepatitis. Normally the immune system reacts to foreign antigens where there is some accumulation in the lymph nodes or spleen which triggers a proliferation of antigen-specific CD8+ T cell. The formation of PD-1 receptor / PD-L1 or B7.1 receptor /PD-L1 ligand complex transmits an inhibitory signal which reduces the proliferation of these CD8+ T cells at the lymph nodes and supplementary to that PD-1 is also able to control the accumulation of foreign antigen specific T cells in the lymph nodes through apoptosis which is further mediated by a lower regulation of the gene Bcl-2.;Species reactivity: Human;Application: ELISA;Assay info: ;Sensitivity: <12pg/ml

    CD274 ELISA Kit (Mouse) (OKBB01000)
    OKBB01000 96 Wells
    EUR 606
    Description: Description of target: Programmed death-ligand 1 (PD-L1), also known as cluster of differentiation 274 (CD274) or B7 homolog 1 (B7-H1), is a protein that in humans is encoded by the CD274 gene. PD-L1 is a 40kDa type 1 transmembrane protein that has been speculated to play a major role in suppressing the immune system during particular events such as pregnancy, tissue allografts, autoimmune disease and other disease states such as hepatitis. Normally the immune system reacts to foreign antigens where there is some accumulation in the lymph nodes or spleen which triggers a proliferation of antigen-specific CD8+ T cell. The formation of PD-1 receptor / PD-L1 or B7.1 receptor /PD-L1 ligand complex transmits an inhibitory signal which reduces the proliferation of these CD8+ T cells at the lymph nodes and supplementary to that PD-1 is also able to control the accumulation of foreign antigen specific T cells in the lymph nodes through apoptosis which is further mediated by a lower regulation of the gene Bcl-2.;Species reactivity: Mouse;Application: ELISA;Assay info: ;Sensitivity: <10pg/ml

    CD274 ELISA Kit (Mouse) (OKAN05739)
    OKAN05739 96 Wells
    EUR 950.4
    Description: Description of target: The protein encoded by this gene is an immune inhibitory receptor ligand that is expressed by hematopoietic and non-hematopoietic cells, such as T cells and B cells and various types of tumor cells. The encoded protein is a type I transmembrane protein that has immunoglobulin V-like and C-like domains. Interaction of this ligand with its receptor inhibits T-cell activation and cytokine production. During infection or inflammation of normal tissue, this interaction is important for preventing autoimmunity by maintaining homeostasis of the immune response. In tumor microenvironments, this interaction provides an immune escape for tumor cells through cytotoxic T-cell inactivation. Mice deficient for this gene display a variety of phenotypes including decreased allogeneic fetal survival rates and severe experimental autoimmune encephalomyelitis.;Species reactivity: Mouse;Application: ELISA;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.055 ng/mL

    CD274 ELISA Kit (Human) (OKAN05757)
    OKAN05757 96 Wells
    EUR 950.4
    Description: Description of target: This gene encodes an immune inhibitory receptor ligand that is expressed by hematopoietic and non-hematopoietic cells, such as T cells and B cells and various types of tumor cells. The encoded protein is a type I transmembrane protein that has immunoglobulin V-like and C-like domains. Interaction of this ligand with its receptor inhibits T-cell activation and cytokine production. During infection or inflammation of normal tissue, this interaction is important for preventing autoimmunity by maintaining homeostasis of the immune response. In tumor microenvironments, this interaction provides an immune escape for tumor cells through cytotoxic T-cell inactivation. Expression of this gene in tumor cells is considered to be prognostic in many types of human malignancies, including colon cancer and renal cell carcinoma. Alternative splicing results in multiple transcript variants.;Species reactivity: Human;Application: ELISA;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.056 ng/mL

    CD274 ELISA Kit (Human) (OKAN05758)
    OKAN05758 96 Wells
    EUR 950.4
    Description: Description of target: This gene encodes an immune inhibitory receptor ligand that is expressed by hematopoietic and non-hematopoietic cells, such as T cells and B cells and various types of tumor cells. The encoded protein is a type I transmembrane protein that has immunoglobulin V-like and C-like domains. Interaction of this ligand with its receptor inhibits T-cell activation and cytokine production. During infection or inflammation of normal tissue, this interaction is important for preventing autoimmunity by maintaining homeostasis of the immune response. In tumor microenvironments, this interaction provides an immune escape for tumor cells through cytotoxic T-cell inactivation. Expression of this gene in tumor cells is considered to be prognostic in many types of human malignancies, including colon cancer and renal cell carcinoma. Alternative splicing results in multiple transcript variants.;Species reactivity: Human;Application: ELISA;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.118 ng/mL

    CD274 ELISA Kit (Human) (OKCD06821)
    OKCD06821 96 Wells
    EUR 903.6
    Description: Description of target: This gene encodes an immune inhibitory receptor ligand that is expressed by hematopoietic and non-hematopoietic cells, such as T cells and B cells and various types of tumor cells. The encoded protein is a type I transmembrane protein that has immunoglobulin V-like and C-like domains. Interaction of this ligand with its receptor inhibits T-cell activation and cytokine production. During infection or inflammation of normal tissue, this interaction is important for preventing autoimmunity by maintaining homeostasis of the immune response. In tumor microenvironments, this interaction provides an immune escape for tumor cells through cytotoxic T-cell inactivation. Expression of this gene in tumor cells is considered to be prognostic in many types of human malignancies, including colon cancer and renal cell carcinoma. Alternative splicing results in multiple transcript variants.;Species reactivity: Human;Application: ELISA;Assay info: ;Sensitivity: < 0.056ng/mL

    CD274 ELISA Kit (Mouse) (OKCD06822)
    OKCD06822 96 Wells
    EUR 934.8
    Description: Description of target: The protein encoded by this gene is an immune inhibitory receptor ligand that is expressed by hematopoietic and non-hematopoietic cells, such as T cells and B cells and various types of tumor cells. The encoded protein is a type I transmembrane protein that has immunoglobulin V-like and C-like domains. Interaction of this ligand with its receptor inhibits T-cell activation and cytokine production. During infection or inflammation of normal tissue, this interaction is important for preventing autoimmunity by maintaining homeostasis of the immune response. In tumor microenvironments, this interaction provides an immune escape for tumor cells through cytotoxic T-cell inactivation. Mice deficient for this gene display a variety of phenotypes including decreased allogeneic fetal survival rates and severe experimental autoimmune encephalomyelitis.;Species reactivity: Mouse;Application: ELISA;Assay info: ;Sensitivity: < 0.055ng/mL

    Cd274 ORF Vector (Rat) (pORF)
    ORF064637 1.0 ug DNA
    EUR 607.2

    CD274 ELISA Kit (Rat) (OKEI00914)
    OKEI00914 96 Wells
    EUR 920.4
    Description: Description of target: ;Species reactivity: Rat;Application: ;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 46.9 pg/mL

    CD274 ORF Vector (Human) (pORF)
    ORF012636 1.0 ug DNA
    EUR 114

    CD274 ELISA Kit (Human) (OKCD09541)
    OKCD09541 96 Wells
    EUR 872.4
    Description: Description of target: This gene encodes an immune inhibitory receptor ligand that is expressed by hematopoietic and non-hematopoietic cells, such as T cells and B cells and various types of tumor cells. The encoded protein is a type I transmembrane protein that has immunoglobulin V-like and C-like domains. Interaction of this ligand with its receptor inhibits T-cell activation and cytokine production. During infection or inflammation of normal tissue, this interaction is important for preventing autoimmunity by maintaining homeostasis of the immune response. In tumor microenvironments, this interaction provides an immune escape for tumor cells through cytotoxic T-cell inactivation. Expression of this gene in tumor cells is considered to be prognostic in many types of human malignancies, including colon cancer and renal cell carcinoma. Alternative splicing results in multiple transcript variants.;Species reactivity: Human;Application: ELISA;Assay info: ;Sensitivity: < 0.112ng/mL

    Cd274 ORF Vector (Mouse) (pORF)
    ORF040831 1.0 ug DNA
    EUR 114

    PD-L1/B7-H1/CD274
    E21-J88 10ug
    EUR 411.6

    pGL3 3 kb prom. CD274
    PVT17995 2 ug
    EUR 360

    pUC18-CD274-T2A-EGFP Plasmid
    PVT15948 2 ug
    EUR 390

    Anti-Hu CD274 PE-Cy7
    T7-177-T100 100 tests
    EUR 321.6

    Anti-Hu CD274 PerCP-Cy5.5
    T9-177-T100 100 tests
    EUR 422.4

    PD-L1 /CD274, Human Recombinant
    P1023-10 each
    EUR 301.2

    PD-L1 /CD274, Human Recombinant
    P1023-50 each
    EUR 823.2

    Rat Anti Mouse Cd274 Monoclonal Antibody,LOW ENDOTOXIN
    CABT-47439RM 0.5 mg
    EUR 1057.2

    Mouse Anti-Human CD274 (PD-L1) mAbConjugated Antibody
    CCM025 100ul
    EUR 476.4

    Programmed Cell Death 1 Ligand 1 (CD274) Antibody
    abx140406-01mg 0.1 mg
    EUR 427.2

    Programmed Cell Death 1 Ligand 1 (CD274) Antibody
    abx224294-100ug 100 ug
    EUR 493.2

    Programmed Cell Death 1 Ligand 1 (CD274) Antibody
    abx414406-025mg 0.25 mg
    EUR 678

    Programmed Cell Death 1 Ligand 1 (CD274) Antibody
    abx414407-05mg 0.5 mg
    EUR 994.8

    Programmed Cell Death 1 Ligand 1 (CD274) Antibody
    abx414408-01mg 0.1 mg
    EUR 526.8

    Programmed Cell Death 1 Ligand 1 (CD274) Antibody
    abx414409-02mg 0.2 mg
    EUR 678

    Programmed Cell Death 1 Ligand 1 (CD274) Antibody
    abx414411-01mg 0.1 mg
    EUR 526.8

    Programmed Cell Death 1 Ligand 1 (CD274) Antibody
    abx412030-01mg 0.1 mg
    EUR 644.4

    Programmed Cell Death 1 Ligand 1 (CD274) Antibody
    abx412147-01mg 0.1 mg
    EUR 844.8

    Anti-Hu CD274 Purified Low Endotoxin
    12-177-C100 0.1 mg
    EUR 189.6

    CD274 sgRNA CRISPR Lentivector set (Human)
    K0407201 3 x 1.0 ug
    EUR 406.8

    Cd274 sgRNA CRISPR Lentivector set (Rat)
    K6192401 3 x 1.0 ug
    EUR 406.8

    Cd274 sgRNA CRISPR Lentivector set (Mouse)
    K4385401 3 x 1.0 ug
    EUR 406.8

    Human, CD274 Human Recombinant Protein, Sf9
    PROTQ9EP73-1 Regular: 10ug
    EUR 380.4
    Description: CD274 Human Recombinant produced in Sf9 Baculovirus cells is a single, glycosylated polypeptide chain containing 462 amino acids (19-238a.a.) and having a molecular mass of 52.5kDa (Molecular size on SDS-PAGE will appear at approximately 50-70kDa). CD274 is expressed with a 239 amino acids hIgG-His tag at C-Terminus and purified by proprietary chromatographic techniques.

    pLKO.1-CD274 shRNA-1 Plasmid
    PVTB00385-3a 2 ug
    EUR 427.2

    pLKO.1-CD274 shRNA-2 Plasmid
    PVTB00385-3b 2 ug
    EUR 427.2

    pLKO.1-CD274 shRNA-3 Plasmid
    PVTB00385-3c 2 ug
    EUR 427.2

    pGL3 2 kb prom. CD274 Plasmid
    PVT17102 2 ug
    EUR 390

    Recombinant CD274 Protein (Met1-Arg238) [His]
    VAng-Cr3786-100g 100 µg
    EUR 880.8
    Description: Recombinant CD274 Protein (Met1-Arg238) fused with a His tag at C-terminus was expressed in Mammalian cells, with a molecular weight of 35 kDa. (Uniprot ID: Q9NZQ7)

    Nori® Bovine CD274 ELISA Kit
    GR112405 96-well
    EUR 461

    PD-L1/CD274 (Human) ELISA Kit
    K4155-100 each
    EUR 966

    Mouse PD-L1 (CD274), Fc fusion
    71117-1 50 µg
    EUR 215
    Description: Mouse secreted Programmed Cell Death 1_x000D_Ligand 1 (PD-L1)-Fc fusion protein, also_x000D_known as CD274 and B7 homolog 1 (B7-_x000D_H1), GenBank Accession No. NM_021893,_x000D_a.a. 19-238, fused at the C-terminus to the_x000D_Fc portion of mouse IgG2a, expressed in a_x000D_HEK293 cell expression system. MW = 51.8_x000D_kDa.

    Mouse PD-L1 (CD274), Fc fusion
    71117-2 100 µg
    EUR 325
    Description: Mouse secreted Programmed Cell Death 1_x000D_Ligand 1 (PD-L1)-Fc fusion protein, also_x000D_known as CD274 and B7 homolog 1 (B7-_x000D_H1), GenBank Accession No. NM_021893,_x000D_a.a. 19-238, fused at the C-terminus to the_x000D_Fc portion of mouse IgG2a, expressed in a_x000D_HEK293 cell expression system. MW = 51.8_x000D_kDa.

    Programmed Cell Death 1 Ligand 1 (CD274) Antibody (PE)
    abx140427-100tests 100 tests
    EUR 577.2

    Programmed Cell Death 1 Ligand 1 (CD274) Antibody (APC)
    abx140453-100tests 100 tests
    EUR 577.2

    CD274 Rabbit Polyclonal Antibody

    Scroll to Top